In investigating the anti-inflammatory properties of butyric acid in diabetes, NaB was found to suppress NF-κB activation and the release of inflammatory cytokines in high-glucose-treated THP-1 cells. This evidence concerns the gene NFKB1 and diabetes mellitus.